Summary of the Article: Paracetamol (acetaminophen) Use During Pregnancy and Neurodevelopmental Outcomes
This article discusses recent research regarding the potential link between paracetamol (acetaminophen) use during pregnancy and neurodevelopmental disorders in children, specifically Autism Spectrum Disorder (ASD), Attention-Deficit/Hyperactivity Disorder (ADHD), and intellectual disability.
Key Findings:
* No Association Found: A systematic review and meta-analysis of 43 studies (with 17 included in the meta-analysis) found no association between paracetamol exposure during pregnancy and the risk of ASD, ADHD, or intellectual disability. This held true for sibling comparison studies,studies with adjusted estimates,and those with longer follow-up periods (over 5 years).
* Confirmation from Other Reviews: These findings align with a November 2025 review of 40 studies and 9 systematic reviews, which also found no link between maternal acetaminophen use and ASD or ADHD.
* Contradiction of Previous Concerns: The research contradicts earlier studies cited by the FDA and the US department of Health and Human Services, which the authors argue suffered from methodological flaws like small sample sizes, self-reported data, and lack of control for confounding factors.
* potential for Confounding: The authors suggest that prolonged paracetamol use might be linked to underlying health conditions that themselves impact neurodevelopment, rather than the drug itself.
* Supports Medical Recommendations: The findings support current recommendations from major medical organizations regarding the use of paracetamol during pregnancy.
In essence,the article presents strong evidence suggesting that paracetamol use during pregnancy is not associated with an increased risk of neurodevelopmental disorders in children.
References:
- D’Antonio F, et al. Lancet Obstet Gynaecol Women’s Health. 2026.
- Halpern L. Pharmacy Times. september 23, 2025. (Accessed January 19, 2026)
